Delhi High Court approves Natco Pharma's CTPR launchNATCOPHARM - 780 Change: -2.25 (-0.29 %)
Natco Pharma has received an order from the Delhi High Court to launch Chlorantraniliprole (CTPR) and its formulations, through its non-infringing process. Natco is the first company in India to have received its registration approval from Central Insecticide Board & Registration Committee (CIB&RC). The company plans to launch its products very shortly.
CTPR technical is formulated into broad spectrum insecticides used across a wide range of crops for pest management. The estimated market size of CTPR containing products in India is ~ Rs 2000 crore. This event is a positive development for Natco as the company had Rs 100 crore of inventory ready and is likely to garner market share being the first to receive registration approval. In total, Natco has invested Rs 165 crore on agro facility while CTPR is a key opportunity.